With China experiencing major trends like slow economic growth, a rapidly aging population, and greater incidence of costly non-communicable diseases, the government has begun a series of reforms to its healthcare system with the aim to increase efficiency and sustainability of the system. While the reforms may have adverse effects on the medical device sector, there remains profitable strategies to take advantage of. Michael Custer, Consultant at Solidiance based in Shanghai, sheds some light on the impacts of the Chinese healthcare reforms on medical device companies and highlights the opportunities to win in China’s fast-growing healthcare market.

Download the article (PDF)